Detalhe da pesquisa
1.
Opioid-induced hypogonadism in opioid use disorder, its role in negative reinforcement, and implications for treatment and retention.
Am J Drug Alcohol Abuse
; 50(2): 132-138, 2024 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320237
2.
Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder.
Am J Addict
; 27(2): 101-107, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29457671
3.
Pharmacotherapy for the Treatment of Cannabis Use Disorder.
Ann Intern Med
; 173(3): 247-248, 2020 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32745456
4.
Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trial.
Exp Clin Psychopharmacol
; 32(1): 112-127, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37732961
5.
The Rise of Prescription Digital Therapeutics in Behavioral Health.
Adv Ther
; 39(12): 5301-5306, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36242730
6.
Applications of technology in the assessment and treatment of cannabis use disorder.
Front Psychiatry
; 13: 1035345, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36339845
7.
Non-abstinent treatment outcomes for cannabis use disorder.
Drug Alcohol Depend
; 225: 108765, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34087745
8.
Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19.
J Addict Med
; 14(6): e297-e302, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956164
9.
The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal.
Neuropsychopharmacology
; 43(1): 173-194, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28875989
10.
Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA.
Acta Neuropathol
; 114(3): 277-86, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17647000